至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

A unique microRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks.

PLoS ONE. 2017; 
Naga PrasadSathyamangla V,GuptaManveen K,DuanZhong-Hui,SurampudiVenkata Suresh K,LiuChang-Gong,KotwalAshwin,MoravecChristine S,StarlingRandall C,PerezDianne M,SenSubha,WuQingyu,PlowEdward F,KarnikSadas
Products/Services Used Details Operation
Gene Synthesis … antagomir for miRNA 214 (5′-CGGACCGACCTGTCTCAACAGTACACAGACGGACAGATG TGAACGACACGTCTTGTAGGCGAGTGGACATGTCGTCCGTGTCTGTCCGTCAGTGTACTG TTGGGTCGGA-3′) were cloned into pRNAT.CMV3.1/Neo (GenScript Corp.) between the … Get A Quote

摘要

It is well established that the gene expression patterns are substantially altered in cardiac hypertrophy and heart failure, however, less is known about the reasons behind such global differences. MicroRNAs (miRNAs) are short non-coding RNAs that can target multiple molecules to regulate wide array of proteins in diverse pathways. The goal of the study was to profile alterations in miRNA expression using end-stage human heart failure samples with an aim to build signaling network pathways using predicted targets for the altered miRNA and to determine nodal molecules regulating individual networks. Profiling of miRNAs using custom designed microarray and validation with an independent set of samples identif... More

关键词